MYT1 and neoplasm: Cdk1 activity is inhibited by phosphorylation induced by Myelin transcription factor 1 (MYT1) and by the reduced expression of Cdk1 phosphatase called cell division cycle 25C (cdc25) (81), which is highly expressed in cancer and is associated with tumor development (82).